Puls versus tägliches orales Cyclophosphamid als Remissionsinduktion bei ANCA-assoziierter Vaskulitis (CYCLOPS-Studie)-Reference-Cited by-同舟云学术

Puls versus tägliches orales Cyclophosphamid als Remissionsinduktion bei ANCA-assoziierter Vaskulitis (CYCLOPS-Studie)

Published:2009-08-05 Issue:7 Volume:68 Page:575-577
ISSN:0340-1855
Container-title:Zeitschrift für Rheumatologie
language:de
Short-container-title:Z. Rheumatol.

Author:

Kötter I.

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00393-009-0509-4.pdf

Reference1 articles.

1. Seror R, Pagnoux C, Rivière S et al for the French Vasculitis Study Group (2009) Characteristics of and rescue-treatment strategies for induction-refractory WG and MPA patients (WEGENT trial). APMIS 117 (Suppl 127):69

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANCA vasculitis and membranoproliferative glomerulonephritis associated with Sjögren’s syndrome: Case report and literature review;Revista Colombiana de Reumatología (English Edition);2022-10

2. Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis;Frontiers in Pharmacology;2022-07-22

3. CNS limited ANCA-associated vasculitis presenting as an isolated intraparenchymal mass;Journal of Neuroimmunology;2022-03

4. Vasculitis ANCA y glomerulonefritis membranoproliferativa asociada con síndrome de Sjögren: reporte de caso y revisión de la literatura;Revista Colombiana de Reumatología;2021-06

5. Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis;Clinical Rheumatology;2017-12-15